Screener
Pacific Biosciences of California PACB Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Pacific Biosciences of California’s reported figures.
Based on trailing twelve months.
The source filing: Pacific Biosciences of California’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 5:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001299130-26-000122
FAQ
- What is Pacific Biosciences of California's free cash flow margin?
- Pacific Biosciences of California (PACB) reported free cash flow margin of -77.5% in Q2 2026.
- How has Pacific Biosciences of California's free cash flow margin changed year-over-year?
- Pacific Biosciences of California's free cash flow margin increased by 20.6% year-over-year, from -97.6% to -77.5%.
- What is the long-term trend for Pacific Biosciences of California's free cash flow margin?
- Over 4 years (2021 to 2025), Pacific Biosciences of California's free cash flow margin has grown at a -5.6% compound annual growth rate (CAGR), from -89.7% to -71.2%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about Pacific Biosciences of California's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude